Workflow
KYTX Investors Have Opportunity to Lead Kyverna Therapeutics, Inc. (NASDAQ: KYTX) Securities Fraud Lawsuit
KYTXKyverna Therapeutics(KYTX) Prnewswire·2024-12-13 06:57

NEW YORK, Dec. 12, 2024 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Kyverna Therapeutics, Inc. (NASDAQ: KYTX) pursuant and/or traceable to the Company's initial public offering conducted on February 8, 2024 (the "IPO"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than February 7, 2025.So what: If you purchased Kyverna com ...